Wesana Health Commences Functional Animal Study for Treatment of Traumatic Brain Injury
11 août 2021 07h30 HE
|
Wesana Health
TORONTO and CHICAGO, Aug. 11, 2021 (GLOBE NEWSWIRE) -- Wesana Health Holdings Inc. (“Wesana” or the “Company”) (CSE: WESA; OTCQB: WSNAF), an emerging data driven life sciences company focused on...
Wesana Health Announces Listing on OTCQB® Venture Market
02 août 2021 09h12 HE
|
Wesana Health
Trading to begin August 2nd, 2021 under the symbol “WSNAF” TORONTO and CHICAGO, Aug. 02, 2021 (GLOBE NEWSWIRE) -- Wesana Health Holdings Inc. (“Wesana” or the “Company”) (CSE: WESA), an emerging...
Ian Burnstein Joins Wesana Health Board of Directors
16 juil. 2021 07h30 HE
|
Wesana Health
TORONTO and CHICAGO, July 16, 2021 (GLOBE NEWSWIRE) -- Wesana Health Holdings Inc. (“Wesana” or the “Company”) (CSE: WESA), an emerging data driven life sciences company focused on developing...
Ian Burnstein Joins Wesana Health Advisory Board
14 juil. 2021 07h30 HE
|
Wesana Health
TORONTO and CHICAGO, July 14, 2021 (GLOBE NEWSWIRE) -- Wesana Health Holdings Inc. (“Wesana” or the “Company”) (CSE: WESA), an emerging data driven life sciences company focused on developing...
Wesana Health Announces Definitive Agreement to Acquire PsyTech Inc.
13 juil. 2021 08h58 HE
|
Wesana Health
CHICAGO and TORONTO, July 13, 2021 (GLOBE NEWSWIRE) -- Wesana Health Holdings Inc. (“Wesana” or the “Company”) (CSE: WESA), an emerging life sciences company focused on developing innovative...
Wesana Health Partners with University of South Carolina
24 juin 2021 16h05 HE
|
Wesana Health
TORONTO and CHICAGO, June 24, 2021 (GLOBE NEWSWIRE) -- Wesana Health Holdings Inc. (“Wesana” or the "Company”) (CSE: WESA), an emerging data driven life sciences company focused on developing...
Wesana Announces Participation at Upcoming Events in June 2021
01 juin 2021 07h37 HE
|
Wesana Health
TORONTO and CHICAGO, June 01, 2021 (GLOBE NEWSWIRE) -- Wesana Health Holdings Inc. (“Wesana” or the “Company”) (CSE: WESA), an emerging data driven life sciences company focused on developing...
Renowned Psychedelic Researcher, James Fadiman, PhD, Joins Wesana Health Scientific Advisory Board
27 mai 2021 08h57 HE
|
Wesana Health
TORONTO and CHICAGO, May 27, 2021 (GLOBE NEWSWIRE) -- Wesana Health Holdings Inc. (“Wesana” or the “Company”) (CSE: WESA), an emerging data driven life sciences company focused on developing...
Wesana Health Expands Research Leadership Team with Mark Wingertzahn, PhD as Chief Scientific Officer
21 mai 2021 07h45 HE
|
Wesana Health
TORONTO and CHICAGO, May 21, 2021 (GLOBE NEWSWIRE) -- Wesana Health Holdings Inc. (“Wesana” or the “Company”) (CSE: WESA), an emerging data-driven life sciences company focused on developing...
The World Boxing Council and Wesana Health Announce Multi-Year Joint Efforts to Research the Impact of Psychedelics on Traumatic Brain Injury
13 mai 2021 07h30 HE
|
Wesana Health
MEXICO CITY and TORONTO and CHICAGO, May 13, 2021 (GLOBE NEWSWIRE) -- The World Boxing Council (“WBC”), boxing’s elite sanctioning body, and Wesana Health Holdings Inc. (“Wesana”) (CSE: WESA), an...